Spirometer flow sensor market seen reaching $1.55 billion by 2030

The spirometer flow sensor market is projected to climb from $1 billion in 2025 to $1.55 billion by 2030, driven by rising respiratory disease rates, more healthcare spending and demand for remote monitoring. North America led in 2025, while Asia-Pacific is expected to grow fastest through 2030.

Why it matters: - Spirometer flow sensors help clinicians measure airflow and lung function, making them central to respiratory diagnosis, monitoring and early disease detection. - The market’s growth points to wider adoption of digital respiratory tools as healthcare systems respond to chronic lung disease, telemedicine and home-based care.

What happened: - The spirometer flow sensor market is projected to rise from $1 billion in 2025 to $1.09 billion in 2026. - The market is forecast to reach $1.55 billion by 2030. - The 2026 to 2030 forecast implies a 9.1% compound annual growth rate. - The report was published by The Business Research Company on July 22, 2026. - Download a free sample of the report. - View the full spirometer flow sensor market report.

The details: - Historical growth was driven by rising chronic respiratory illness, more hospital-based pulmonary function tests, greater awareness of early lung disease detection, expanded diagnostic laboratory infrastructure and basic digital spirometry technology. - Forecast growth is tied to demand for remote respiratory monitoring, home healthcare and telemedicine, AI-enhanced diagnostic precision, preventive screening programs and connected medical devices. - Reported trend areas include AI-powered respiratory diagnostics for real-time lung function analysis, IoT-enabled spirometer sensors for remote patient monitoring, cloud-based pulmonary function testing platforms, portable handheld devices for home use and higher demand for high-accuracy digital airflow measurement tools in clinical settings. - A spirometer flow sensor measures the volume and speed of air inhaled and exhaled by a person. - The sensor converts airflow changes into electrical signals that can be analyzed to assess respiratory function. - The report identifies increasing respiratory disease prevalence as a major demand driver. - Air pollution is a cited contributor to rising respiratory illness because prolonged exposure to fine particulate matter, vehicle emissions and industrial smoke can damage lung tissue. - The report cites UK Health Security Agency data showing tuberculosis cases in England rose 13% in 2024 to 5,480 from 4,850 in 2023. - Rising healthcare spending is another demand driver because higher budgets support respiratory diagnostics, monitoring and treatment. - UK Office for National Statistics data showed total healthcare expenditure rose 6.5% in nominal terms and 2.4% in real terms from 2023 to 2024. - UK government-funded healthcare spending reached $328 billion (£258 billion) in 2024, up 2.5% in real terms from the prior year. - North America held the largest market share in 2025. - Asia-Pacific is expected to post the fastest growth over the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The forecast suggests spirometer flow sensors are moving from a niche diagnostic component toward a broader role in connected and distributed respiratory care. - The strongest growth themes cluster around remote care, which often lowers the need for in-person testing while expanding monitoring demand outside hospitals. - The market outlook also reflects a shift from basic measurement toward software-enabled diagnostics and device integration.

What's next: - Demand will likely track adoption of home healthcare, telemedicine and preventive screening as respiratory care becomes more decentralized. - Product development appears set to focus on portable devices, connected sensors and AI-based analysis tools. - Regional growth may increasingly favor Asia-Pacific as healthcare infrastructure and diagnostic access expand.